Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

An Erratum to this article was published on 21 November 1996

Abstract

APUTATIVE chemokine receptor that we previously cloned and termed LESTR1 has recently been shown to function as a co-receptor (termed fusin) for lymphocyte-tropic HIV-1 strains2. Cells expressing CD4 became permissive to infection with T-cell-line-adapted HIV-1 strains of the syncytium-inducing phenotype after transfection with LESTR/fusin complementary DNA. We report here the identification of a human chemokine of the CXC type, stromal cell-derived factor 1 (SDF-1), as the natural ligand for LESTR/fusin, and we propose the term CXCR-4 for this receptor, in keeping with the new chemokine-receptor nomenclature. SDF-1 activates Chinese hamster ovary (CHO) cells transfected with CXCR-4 cDNA as well as blood leukocytes and lymphocytes. In cell lines expressing CXCR-4 and CD4, and in blood lymphocytes, SDF-1 is a powerful inhibitor of infection by lymphocyte-tropic HIV-1 strains, whereas the CC chemokines RANTES, MIP-lα and MIP-1β, which were shown previously to prevent infection with primary, monocyte-tropic viruses3, are inactive. In combination with CC chemokines, which block the infection with monocyte/macrophage-tropic viruses, SDF-1 could help to decrease virus load and prevent the emergence of the syncytium-inducing viruses which are characteristic of the late stages of AIDS4.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Loetscher, M., Geiser, T., O'Reilly, T., Zwahlen, R., Baggiolini, M. & Moser, B. J. Biol. chem. 269, 232–237 (1994).

    CAS  PubMed  Google Scholar 

  2. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. Science 272, 872–877 (1996).

    Article  ADS  CAS  PubMed  Google Scholar 

  3. Cocchi, F. et al. Science 270, 1811–1815 (1995).

    Article  ADS  CAS  PubMed  Google Scholar 

  4. Weiss, R. A. Science 272, 1885–1886 (1996).

    Article  ADS  CAS  PubMed  Google Scholar 

  5. Tashiro, K. et al. Science 261, 600–603 (1993).

    Article  ADS  CAS  PubMed  Google Scholar 

  6. Nagasawa, T., Kikutani, H. & Kishimoto, T. Proc. Natl Aced. Sd. USA 91, 2305–2309 (1994).

    Article  ADS  CAS  Google Scholar 

  7. Bleul, C. C., Fuhlbigge, R. C., Casasnovas, J. M., Aiuti, A. & Springer, T. A. J. Exp. Med. (in the press).

  8. Baggiolini, M., Dewald, B. & Moser, B. Adv. Immunol. 55, 97–179 (1994).

    Article  CAS  PubMed  Google Scholar 

  9. Nomura, H., Nielsen, B. W. & Matsushima, K. Int. Immunol. 5, 1239–1249 (1993).

    Article  CAS  PubMed  Google Scholar 

  10. Adachi, A. et al. J. Virol. 59, 284–291 (1986).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Deng, H. K. et al. Nature 381, 661–666 (1996).

    Article  ADS  CAS  PubMed  Google Scholar 

  12. Dragic, T. et al. Nature 381, 667–673 (1996).

    Article  ADS  CAS  PubMed  Google Scholar 

  13. Alkhatib, G. et al. Science 272, 1955–1958 (1996).

    Article  ADS  CAS  PubMed  Google Scholar 

  14. Choe, H. et al. Cell 85, 1135–1148 (1996).

    Article  CAS  PubMed  Google Scholar 

  15. Doranz, B. J. et al. Cell 85, 1149–1158 (1996).

    Article  CAS  PubMed  Google Scholar 

  16. Yee, J. K. et al. Proc. Natl Aced. Sci. USA 91, 9564–9568 (1994).

    Article  ADS  CAS  Google Scholar 

  17. Jazin, E. E. et al. Regul. Pept. 47, 247–258 (1993).

    Article  CAS  PubMed  Google Scholar 

  18. Clark-Lewis, I. et al. Biochemistry 30, 3128–3135 (1991).

    Article  CAS  PubMed  Google Scholar 

  19. Peveri, P., Walz, A., Dewald, B. & Baggiolini, M. J. Exp.Med. 167, 1547–1559 (1988).

    Article  CAS  PubMed  Google Scholar 

  20. Uguccioni, M., D'Apuzzo, M., Loetscher, M., Dewald, B. & Baggiolini, M. Eur. J. Immunol. 25, 64–68 (1995).

    Article  CAS  PubMed  Google Scholar 

  21. Colotta, F., Peri, G., Villa, A. & Mantovani, A. J. Immunol. 132, 936–944 (1984).

    CAS  PubMed  Google Scholar 

  22. von Tscharner, V., Prod'hom, B., Baggiolini, M. & Reuter, H. Nature 324, 369–372 (1986).

    Article  ADS  CAS  PubMed  Google Scholar 

  23. Cann, A. J. et al. J. Virol. 64, 4735–4742 (1992).

    Google Scholar 

  24. Li, Y. et al. J. Virol. 66, 6587 - (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Clavel, F. & Charneau, P. J. Virol. 68, 1179–1185 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Jacque, J. M. et al. J. Virol. 70, 2930–2938 (1996).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oberlin, E., Amara, A., Bachelerie, F. et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833–835 (1996). https://doi.org/10.1038/382833a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/382833a0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing